Mind the gap: Lack of association between KIR3DL1*004/HLA-Bw4-induced natural killer cell function and protection from HIV infection

Journal of Infectious Diseases

Volumn 202, Issue SUPP.3, 2010, Pages

  Parsons, Matthew S ^a   Boulet, Salix ^a,c   Song, Rujun ^a   Bruneau, Julie ^b   Shoukry, Naglaa H ^b   Routy, Jean Pierre ^a   Tsoukas, Christos M ^a   Bernard, Nicole F ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA BW4 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; LIGAND; UNCLASSIFIED DRUG; HLA BW4; HLA-BW4; KIR3DL1 PROTEIN, HUMAN;

ALLELE; CELL STRAIN K 562; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; FLOW CYTOMETRY; GENE LOCUS; GENOTYPE; HETEROZYGOTE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENETICS; INFECTION PREVENTION; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; RISK REDUCTION; SERODIAGNOSIS; ARTICLE; GENE FREQUENCY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; INNATE IMMUNITY;

GENE FREQUENCY; HIV; HIV INFECTIONS; HLA-B ANTIGENS; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; RECEPTORS, KIR3DL1;

EID: 78049451424     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/655966     Document Type: Conference Paper

References (21)

1. Miyazawa M, Lopalco L, Mazzotta F, et al. The 'immunologic advantage' of HIV-exposed seronegative individuals. AIDS 2009; 23:161-175.
2. Piacentini L, Biasin M, Fenizia C, Clerici M. Genetic correlates of protection against HIV infection: the ally within. J Intern Med 2009; 265:110-124.
3. Boulet S, Kleyman M, Kim JY, et al. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS 2008; 22:1487-1491.
4. Boulet S, Sharafi S, Simic N, et al. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 2008; 22:595-599. (Pubitemid 351640592)
5. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002; 31:429-434.
6. Martin MP, Qi Y, Gao X, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007; 39:733-740.
7. Sanabria MX, Vargas-Inchaustegui DA, Xin L, Soong L. Role of natural killer cells in modulating dendritic cell responses to Leishmania amazonensis infection. Infect Immun 2008; 76:5100-5109.
8. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23:225-274.
9. Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005; 436:709-713.
10. Anfossi N, Andre P, Guia S, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006; 25:331-342.
11. Kim S, Sunwoo JB, Yang L, et al. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A 2008; 105:3053-3058.
12. Yokoyama WM, Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 2006; 214:143-154. (Pubitemid 44707908)
13. Pando MJ, Gardiner CM, Gleimer M, McQueen KL, Parham P. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 2003; 171:6640-6649.
14. Thomas R, Yamada E, Alter G, et al. Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? J Immunol 2008; 180:6743-6750.
15. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 2006; 203:633-645.
16. Boulet S, Song R, Kamya P, et al. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. J Immunol 2010; 184:2057-2064.
17. Pascal V, Yamada E, Martin MP, et al. Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. J Immunol 2007; 179:1625-1633.
18. Carr WH, Rosen DB, Arase H, Nixon DF, Michaelsson J, Lanier LL. Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol 2007; 178:647-651.
19. Chalifour A, Scarpellino L, Back J, et al. A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity 2009; 30: 337-347.
20. Brodin P, Karre K, Hoglund P. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 2009; 30: 143-149.
21. Alter G, Martin MP, Teigen N, et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007; 204:3027-3036.